Sirolimus versus imatinib in patients with steroid-refractory chronic graft-versus-host disease: a retrospective analysis of a single-center
Objective To compare the efficacy and prognosis of imatinib and sirolimus as second-line treatment for steroid-refractory chronic graft-versus-host disease (SR-cGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods Clinical data of 33 patients diagnosed as SR-cGVHD afte...
Enregistré dans:
Auteurs principaux: | HE Yundi, HUANG Ruihao, HONG Tao, WANG Weihao, DU Yuxuan |
---|---|
Format: | article |
Langue: | ZH |
Publié: |
Editorial Office of Journal of Third Military Medical University
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/413c7351afd84e67a2f6d92b036de682 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients
par: Wei C, et autres
Publié: (2021) -
CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
par: Takahashi,Hiroshi, et autres
Publié: (2015) -
Effect and mechanism of human umbilical cord mesenchymal stem cells on preventing murine acute graft-versus-host disease
par: HONG Tao, et autres
Publié: (2021) -
Letermovir Prophylaxis and Cytomegalovirus Reactivation in Adult Hematopoietic Cell Transplant Recipients with and without Acute Graft Versus Host Disease
par: Delaney Wolfe, et autres
Publié: (2021) -
Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease
par: Aditya Rayasam, et autres
Publié: (2021)